Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization.
Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other aut...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3463516?pdf=render |
| _version_ | 1819042795250253824 |
|---|---|
| author | Rajesh Ringe Lipsa Das Ipsita Choudhary Deepak Sharma Ramesh Paranjape Virander Singh Chauhan Jayanta Bhattacharya |
| author_facet | Rajesh Ringe Lipsa Das Ipsita Choudhary Deepak Sharma Ramesh Paranjape Virander Singh Chauhan Jayanta Bhattacharya |
| author_sort | Rajesh Ringe |
| collection | DOAJ |
| description | Broadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other autologous env clones). The enhanced autologous neutralization of pseudotyped viruses expressing the sensitive envelope (Env) was associated with increased sensitivity to reagents and monoclonal antibodies targeting distinct sites in Env. Chimeric viruses constructed by swapping fragments of sensitive Env into resistant Env backbone revealed that the presence of unique residues within C2V3 region of gp120 governed increased neutralization. The enhanced virus neutralization was also associated with low CD4 dependence as well as increased binding of Env trimers to IgG1b12 and CD4-IgG2 and was independent of gp120 shedding. Our data highlighted vulnerabilities in the Env obtained from cross neutralizing plasma associated with the exposure of discontinuous neutralizing epitopes and enhanced autologous neutralization. Such information may aid in Env-based vaccine immunogen design. |
| first_indexed | 2024-12-21T09:46:34Z |
| format | Article |
| id | doaj.art-161ab5a0a66542f6a7aee5da35226148 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T09:46:34Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-161ab5a0a66542f6a7aee5da352261482022-12-21T19:08:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4671310.1371/journal.pone.0046713Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization.Rajesh RingeLipsa DasIpsita ChoudharyDeepak SharmaRamesh ParanjapeVirander Singh ChauhanJayanta BhattacharyaBroadly neutralizing antibodies to HIV-1 usually develops in chronic infections. Here, we examined the basis of enhanced sensitivity of an env clone amplified from cross neutralizing plasma of an antiretroviral naïve chronically infected Indian patient (ID50 >600-fold higher compared to other autologous env clones). The enhanced autologous neutralization of pseudotyped viruses expressing the sensitive envelope (Env) was associated with increased sensitivity to reagents and monoclonal antibodies targeting distinct sites in Env. Chimeric viruses constructed by swapping fragments of sensitive Env into resistant Env backbone revealed that the presence of unique residues within C2V3 region of gp120 governed increased neutralization. The enhanced virus neutralization was also associated with low CD4 dependence as well as increased binding of Env trimers to IgG1b12 and CD4-IgG2 and was independent of gp120 shedding. Our data highlighted vulnerabilities in the Env obtained from cross neutralizing plasma associated with the exposure of discontinuous neutralizing epitopes and enhanced autologous neutralization. Such information may aid in Env-based vaccine immunogen design.http://europepmc.org/articles/PMC3463516?pdf=render |
| spellingShingle | Rajesh Ringe Lipsa Das Ipsita Choudhary Deepak Sharma Ramesh Paranjape Virander Singh Chauhan Jayanta Bhattacharya Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. PLoS ONE |
| title | Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. |
| title_full | Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. |
| title_fullStr | Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. |
| title_full_unstemmed | Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. |
| title_short | Unique C2V3 sequence in HIV-1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization. |
| title_sort | unique c2v3 sequence in hiv 1 envelope obtained from broadly neutralizing plasma of a slow progressing patient conferred enhanced virus neutralization |
| url | http://europepmc.org/articles/PMC3463516?pdf=render |
| work_keys_str_mv | AT rajeshringe uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT lipsadas uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT ipsitachoudhary uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT deepaksharma uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT rameshparanjape uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT virandersinghchauhan uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization AT jayantabhattacharya uniquec2v3sequenceinhiv1envelopeobtainedfrombroadlyneutralizingplasmaofaslowprogressingpatientconferredenhancedvirusneutralization |